News for hackers. Stuff that matters.
Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by BriggyDwiggs42 on Sunday September 08, 2024 @05:14PM (#41483267)
We probably should let them if they’ve exhausted other options right?
Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by bawolff on Sunday September 08, 2024 @05:42PM (#41483475)
I think the main worry is scam artists who essentially pray on desperate people with "cures" that do nothing at best and shorten their lives at worse.

I'm fine with letting people try whatever they want if there are no other options (their life, although informed consent is tricky) however i dont think we should allow marketing such things to patients or allow anyone making money off it.

Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by Loughla on Sunday September 08, 2024 @10:02PM (#41484879)
Exactly. They should be able to take whatever experimental drugs might be available.

The problem is, how do companies identify these patients or how do patients identify these companies without leaving room for massive abuse.

Maybe the treatments have to be zero cost? That feels like it would eliminate all bad actors?

Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by BriggyDwiggs42 on Wednesday September 11, 2024 @02:16PM (#41513910)
That’s actually kinda a great idea imo
Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by ALittleLight on Monday September 09, 2024 @03:26AM (#41486215)
There are already plenty of people who promote scam cures. We shouldn't deny potentially useful treatments to patients in dire need just to reduce somewhat the business of scammers.

Detect and punish scammers if they are an issue. Allow people to take risky medical treatments if they have serious incurable illnesses.

Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by XorNot on Monday September 09, 2024 @03:42AM (#41486294)
You're not adding money to the mix.

If a company or research group wants to sponsor an experimental treatment with patient approval and waiver free of charge, that's one thing.

But they almost immediately turn around and say " oh we'll need to cover costs..." and suddenly the incentive is very different.

Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by melling on Sunday September 08, 2024 @05:25PM (#41483355)
Let them what? Enroll in a clinical trial? Buy drugs from some website?

Get a PhD to try and cure their own disease?

https://www.wired.com/story/sleep-no-more-crusade-genetic-ki...

Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by wslh on Sunday September 08, 2024 @05:34PM (#41483423)
I believe the main point is to allow the patient to choose from a set of treatments. Correct me if I’m wrong, but isn’t this already happening at some level, where patients receive treatments that are in advanced stages of drug trials?

I imagine there could be other options available, and many times the issues are related to logistics, bureaucracy, and corruption. For instance, many people around the world go hungry due to logistical challenges (e.g., political interference) [1].

It seems we accept the status quo, while some companies are sending cheaper spacecraft into space.

[1] https://www.reddit.com/r/NoStupidQuestions/comments/zye4gm/w...

Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by melling on Sunday September 08, 2024 @05:42PM (#41483473)
People can enroll in clinical trials.

https://clinicaltrials.gov/

Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by wslh on Sunday September 08, 2024 @07:29PM (#41484143)
That page is for information, not for enrolling.
Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by melling on Sunday September 08, 2024 @07:46PM (#41484259)
Each study tells if they are recruiting.

Then you can drill down and see locations where they are recruiting. For example,

https://clinicaltrials.gov/study/NCT05855200?locStr=New%20Yo...

Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by baq on Monday September 09, 2024 @01:16AM (#41485650)
Health care is not a farmer’s market. You don’t pick from ten different kinds of potatoes. There will be tons of people with magic treatments with no statistical evidence or even fraudulent data. Snake oil, literally. Net negative for society.
Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by wslh on Monday September 09, 2024 @05:53AM (#41486913)
Sure, but when someone reaches the final stages of life, the logic shifts. This is similar to the debate around euthanasia: do individuals have the right to end their lives or choose alternative treatments, even without strong statistical backing? Your comment also raises another important question: does the "net negative for society" truly matter in these cases? That's a political perspective, and like euthanasia, it's subject to debate.
Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by baq on Monday September 09, 2024 @06:24AM (#41487071)
I respectfully disagree. Selling desperate people fraudulent stuff for real money will never not be net negative for society in my view.
Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by wslh on Monday September 09, 2024 @08:46AM (#41488000)
I am firmly against selling fraudulent products to people, but I also believe there are ways to introduce unconventional treatments, like those from an 'irreverent Dr. House.'. I think regulations should evolve to keep pace with the acceleration of science, as seen when the COVID vaccine was developed swiftly in response to urgent needs.
Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by scythe on Monday September 09, 2024 @02:05AM (#41485865)
Once you've actually exhausted all other options, even a treatment that works probably won't save your life. Breakthrough treatments usually make a bigger difference when the conventional 5-year survival rate is around 20%, not 0%. Most "broad-spectrum" cancer treatments (radiation, cell division inhibitors, surgery) tend to cause permanent damage to multiple organs.
Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by soco on Monday September 09, 2024 @04:14AM (#41486461)
All other considerations aside, the technical detail defining this case is that she administered herself this treatment before other options. Which made all the difference, and which makes it not an option "if they've exhausted other options"...
Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by cma on Monday September 09, 2024 @07:39AM (#41487550)
You can't see any externality risks to nonconsenters of having people use unapproved viruses on themselves sold from hucksters on TV infomercials and stuff?
Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by BriggyDwiggs42 on Wednesday September 11, 2024 @03:27AM (#41508930)
Easy, don’t let hucksters make TV infomercials promoting their snake oil.
Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by CipherThrowaway on Monday September 09, 2024 @10:06AM (#41488712)
Exhausting all treatment options is not the same as having nothing to close.

There's no shortage of cancer patients at end-of-life stage undergoing aggressive treatments and/or experimental therapies in clinical trials for minimal to no survival benefit. For almost all of these patients, the best option for them and their loved ones will end up having been a palliative or best supportive care model.

Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth... by BriggyDwiggs42 on Wednesday September 11, 2024 @03:25AM (#41508916)
But despite this, isn’t it their right to try in the hope that they can be the lucky one to get more years of life?